Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 197
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First Look at Gilgamesh’s Phase 2a Data; ASCP 2025 Preview; VA Sec. Pressed on...
EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic Access for Veterans
Ibogaine – The Promise, the Protocol, and Protecting the Sacred
Pα+ Psychedelic Bulletin #195: Psychedelics Namechecked in Trump Cabinet Meeting; Noma Therapy Aims to Disrupt At-Home Ketamine; Christian Angermayer on the Politics and Business...
“Neuropharmacology: Psychedelics on the Brain” – Jim Harris, Rachel Zoeller, DPT, David W. Mcmillan, Ph.D., and Manesh Girn, Ph.D.
Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial...
Psychedelic Bulletin: Small Pharma Secures Fast-Track Designation in UK; Boris Johnson...
More Evidence of the Chemical Compound Variability in Magic Mushrooms
PTSF82 – Wonderland Miami, with Patrick Moher of Microdose
Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy...
Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in...
Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
Open-label study of COMP360 psilocybin therapy for depression in cancer patients...
PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine...
COMPASS Pathways is granted new US patent for crystalline psilocybin
1
...
196
197
198
...
286
Page 197 of 286
